Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:p>Polyclonal and monoclonal antisera raised to tetanus toxoid-conjugated polysaccharide of lipopolysaccharide (<jats:sc>lps</jats:sc>) and purified<jats:sc>lps</jats:sc>of<jats:italic>Pseudomonas pseudomallei</jats:italic>that reacted with a collection of 41 strains of this bacterium from 23 patients are described. The common antigen recognized by these sera was within the polysaccharide component of the<jats:sc>lps</jats:sc>of the cells. The sera were specific for<jats:italic>P pseudomallei</jats:italic>in that none of 37 strains of other bacteria, including 20 Gram-negative and three Gram-positive species, were recognized, although cross-reaction occurred using the anticonjugate serum with some strains of<jats:italic>Pseudomonas cepacia</jats:italic>serotype A, a closely related bacterium. Passive protection studies using a diabetic rat model of<jats:italic>P pseudomallei</jats:italic>infection showed that partially purified rabbit polyclonal and mouse monoclonal antisera were protective when the median lethal dose was raised by four to five orders of magnitude. The wide distribution of the polysaccharide antigen among isolates of<jats:italic>P pseudomallei</jats:italic>used in this study and the protective role of antibody to the conjugated polysaccharide antigen suggest potential as a vaccine.</jats:p>

Original publication





Canadian Journal of Infectious Diseases


Hindawi Limited

Publication Date





170 - 178